Persistent Fever after COVID-19 Vaccination in a Patient with Ulcerative Colitis : A Call for Attention
© 2023 The Author(s).Published by S. Karger AG, Basel..
The development of vaccinations has been game-changing in the ongoing effort to combat the COVID-19 pandemic. Until now, adverse effects are being reported at low frequency, including thrombocytopenia and myocarditis. Careful monitoring for any suspicious symptoms and signs following vaccination is necessary. We report a case of hemophagocytic lymphohistiocytosis (HLH) after mRNA COVID-19 vaccine in a 23-year-old female with ulcerative colitis. Diagnosis was made according to HLH-2004 criteria and the patient was treated with dexamethasone with response. Our report aimed to draw attention to the potential relation between COVID-19 vaccines and HLH and the necessity of continued surveillance, especially in at-risk populations such as those with underlying immune dysregulation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
GE Portuguese journal of gastroenterology - 31(2024), 2 vom: 12. Apr., Seite 129-135 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rodrigues, Cláudio Melo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 vaccination |
|---|
| Anmerkungen: |
Date Revised 05.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1159/000530834 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370618637 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370618637 | ||
| 003 | DE-627 | ||
| 005 | 20240405234335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240405s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000530834 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1366.xml |
| 035 | |a (DE-627)NLM370618637 | ||
| 035 | |a (NLM)38572438 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rodrigues, Cláudio Melo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Persistent Fever after COVID-19 Vaccination in a Patient with Ulcerative Colitis |b A Call for Attention |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Author(s).Published by S. Karger AG, Basel. | ||
| 520 | |a The development of vaccinations has been game-changing in the ongoing effort to combat the COVID-19 pandemic. Until now, adverse effects are being reported at low frequency, including thrombocytopenia and myocarditis. Careful monitoring for any suspicious symptoms and signs following vaccination is necessary. We report a case of hemophagocytic lymphohistiocytosis (HLH) after mRNA COVID-19 vaccine in a 23-year-old female with ulcerative colitis. Diagnosis was made according to HLH-2004 criteria and the patient was treated with dexamethasone with response. Our report aimed to draw attention to the potential relation between COVID-19 vaccines and HLH and the necessity of continued surveillance, especially in at-risk populations such as those with underlying immune dysregulation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 vaccination | |
| 650 | 4 | |a Hemophagocytic lymphohistiocytosis | |
| 650 | 4 | |a Ulcerative colitis | |
| 700 | 1 | |a Carvalho, Ana Catarina |e verfasserin |4 aut | |
| 700 | 1 | |a Ventura, Sofia |e verfasserin |4 aut | |
| 700 | 1 | |a Domingues, Ângela Pinto |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Américo |e verfasserin |4 aut | |
| 700 | 1 | |a Ministro, Paula |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t GE Portuguese journal of gastroenterology |d 2015 |g 31(2024), 2 vom: 12. Apr., Seite 129-135 |w (DE-627)NLM275213137 |x 2341-4545 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2024 |g number:2 |g day:12 |g month:04 |g pages:129-135 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000530834 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2024 |e 2 |b 12 |c 04 |h 129-135 | ||